Hamden, CT --- March 21, 2011 --- RxGen, a specialty preclinical contract research organization, announced today that Experimental Eye Research has published results of efforts to optimize the laser-induced choroidal neovascularization (CNV) model in nonhuman primates, which is routinely employed to evaluate candidate compounds or drug delivery devices designed to treat wet-AMD. Despite widespread use of ...
Therapeutic Development Through Innovative Research
Monthly Archives: March 2011
